 **Medical Articles**


> Source: CDC


**Topic: CDC identifies four urgent antimicrobial resistance threats**

The CDC’s 2026 antimicrobial resistance report identifies **19 drug-resistant pathogens** responsible for an estimated 9.7 million infections and 50,800 deaths annually in the United States. Four are classified as urgent threats: _Candida auris_, carbapenem-resistant _Acinetobacter_, carbapenem-resistant Enterobacterales (CRE), and drug-resistant _Neisseria gonorrhoeae_.
Several findings deserve particular attention:
**Gonorrhea:** Reduced ceftriaxone susceptibility remained rare (0.1% of isolates in 2023), but resistance or reduced susceptibility to at least one monitored antibiotic increased to 55.4%.
**C. auris:** Clinical cases have increased nearly tenfold since 2019, with emerging echinocandin resistance.
**CRE:** New Delhi metallo-β-lactamase (NDM)-producing infections increased nearly fivefold between 2019 and 2023.
**Pertussis:** Macrolide-resistant cases remain rare, with only two identified in 2024–2025.

**Link:** [https://arthreats.cdc.gov/](https://arthreats.cdc.gov/)

[@HakimApps_Guideline](https://t.me/HakimApps_Guideline)